Skip to main content

Advertisement

SpringerLink
Log in

Mortality of Chinese patients with polymyositis and dermatomyositis

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

Objective

To investigate the mortality and the causes of death in Chinese patients with polymyositis (PM) and dermatomyositis (DM).

Methods

The clinical data of all consecutive adult PM/DM patients in Rheumatology and clinical immunology department of Peking University First Hospital from January 2007 to Apr2016 were collected. The primary causes of death were identified, the standardized mortality ratio (SMR) and years of life lost (YLL) were calculated based on the National Bureau of Statistics of China for the general population, the survival in the first decade was performed using Kaplan-Meier analysis, and the predictors of mortality were evaluated by multivariable cox regression.

Results

A total of 85 PM and226 DM cases were included and 68 patients died. Infection (52.3%) was the leading cause of death. The overall age and sex adjusted SMR was 6.0(95%CI 3.5–8.5) for PM, and 9.0(95%CI 6.8–11.2) for DM. The YLL of women and men were 12.2 and 18.3 years respectively for PM, and 37.5 and 28.4 years respectively for DM. The 10-year survival of patients with ILD, malignancy or infection was significantly worse than those without, respectively. The independent predictors of mortality for PM/DM patients were age at disease onset, malignancy and infection.

Conclusions

Mortality of PM/DM patients in China is substantial, especially in females, and those with ILD, malignancy or infection. Infection was the leading cause of death. Patients with older age at onset, infection, ILD, and malignancy need to be paid more attention.

Key Points

• This is the first comprehensive report about the mortality situation with a large population in PM/DM patients in China including SMR, YLL, and cause of death, Kaplan-Meier survival analysis and Cox regression analysis for mortality risk factors.

• The specific SMRs for PM/DM patients with malignancy and interstitial lung disease were also reported in this study. To our knowledge, only two studies worldwide reported SMRs in PM/DM patients and no figure about YLL was reported so far.

• Overall, the mortality figures in this study were higher than those from the western countries, and the leading cause of death was different from the western countries.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3

Similar content being viewed by others

Data availability

The datasets analyzed during the current study are available from the corresponding author upon reasonable request.

References

  1. Dalakas MC (2015) Inflammatory muscle diseases. N Engl J Med 372:1734–1747

    Article  PubMed  Google Scholar 

  2. Lilleker JB, Vencovsky J, Wang G, Wedderburn LR, Diederichsen LP, Schmidt J, Oakley P, Benveniste O, Danieli MG, Danko K, Thuy NTP, Vazquez-del Mercado M, Andersson H, de Paepe B, deBleecker J, Maurer B, McCann L, Pipitone N, McHugh N, Betteridge ZE, New P, Cooper RG, Ollier WE, Lamb JA, Krogh NS, Lundberg IE, Chinoy H, all EuroMyositis contributors (2018) The EuroMyositis registry: an international collaborative tool to facilitate myositis research. Ann Rheum Dis 77(1):30–39

    Article  PubMed  Google Scholar 

  3. Dobloug GC, Svensson J, Lundberg IE, Holmqvist M (2018) Mortality in idiopathic inflammatory myopathy: results from a Swedish nationwide population-based cohort study. Ann Rheum Dis 77(1):40–47

    Article  PubMed  Google Scholar 

  4. Marie I (2012) Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 14:275–285

    Article  CAS  PubMed  Google Scholar 

  5. Nuno-Nuno L, Joven BE, Carreira PE, Maldonado-Romero V, Larena-Grijalba C, Cubas IL et al (2017) Mortality and prognostic factors in idiopathic inflammatory myositis: a retrospective analysis of a large multicenter cohort of Spain. Rheumatol Int 37(11):1853–1861

    Article  PubMed  Google Scholar 

  6. Mustafa KN, Dahbour SS (2010) Clinical characteristics and outcomes ofpatients with idiopathic inflammatory myopathies from Jordan 1996–2009. Clin Rheumatol 29:1381–1385

    Article  PubMed  Google Scholar 

  7. Yu KH, Wu YJ, Kuo CF, See LC, Shen YM, Chang HC, Luo SF, Ho HH, Chen IJ (2011) Survival analysis of patients withdermatomyositis and polymyositis: analysis of 192 Chinese cases. Clin Rheumatol 30:1595–1601

    Article  PubMed  Google Scholar 

  8. Schiopu E, Phillips K, Macdonald PM, Crofford LJ, Somers EC (2012) Predictors ofsurvival in a cohort of patients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate, and azathioprine. Arthritis Res Ther 14:R22

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  9. Yamasaki Y, Yamada H, Ohkubo M, Yamasaki M, Azuma K, Ogawa H, Mizushima M, Ozaki S (2011) Longterm survivaland associated risk factors in patients with adult-onset idiopathic inflammatory myopathies and amyopathic dermatomyositis:experience in a single institute in Japan. J Rheumatol 38:1636–1643

    Article  CAS  PubMed  Google Scholar 

  10. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347

    Article  CAS  PubMed  Google Scholar 

  11. Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407

    Article  CAS  PubMed  Google Scholar 

  12. Sontheimer RD (2002) Would a new name hasten the acceptanceof amyopathic dermatomyositis (dermatomyositissine´ myositis) as a distinctive subset within the idiopathicinflammatorydermatomyopathies spectrum of clinical illness? J Am Acad Dermatol 46:626–636

    Article  PubMed  Google Scholar 

  13. Lundberg IE, Miller FW, Tjärnlund A et al (2016) Diagnosis and classification of idiopathicinflammatory myopathies. J Intern Med 280:39–51

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  14. American Thoracic Society, European Respiratory Society (2002) American Thoracic Society/European RespiratorySociety international multidisciplinary consensus classificationof the idiopathic interstitial pneumonias. Am J Respir Crit Care Med 165:277–304

    Article  Google Scholar 

  15. Sato S, Masui K, Nishina N, Kawaguchi Y, Kawakami A, Tamura M et al (2018) Initial predictors of poor survival in myositis-associated interstitial lung disease: a multicentre cohort of 497 patients. Rheumatology 57:1212–1221

  16. Schwartz T, Diederichsen LP, Lundberg IE et al (2016) Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies. RMD Open 2:e000291

    Article  PubMed  PubMed Central  Google Scholar 

  17. Gosselink R, Kovacs L, Decramer M (1999) Respiratory muscle involvement in multiple sclerosis. Eur Respir J 13:449–454

    Article  CAS  PubMed  Google Scholar 

  18. Lee PP, Lee TL, Ho MH, Wong WH, Lau YL (2007) Recurrent major infections injuvenile-onset systemic lupus erythematosus–a close linkwith long-term disease damage. Rheumatology 46:1290–1296

    Article  CAS  PubMed  Google Scholar 

  19. Andersen PK, Borgan O, Gill RD, Keiding N (1993) Statistical models based on counting processes. Springer-Verlag, New York, p 322

    Book  Google Scholar 

  20. Mok CC, Kwok CL, Ho LY, Chan PT, Yip SF (2011) Life expectancy, standardized mortality ratios, and causes of death in six rheumatic diseases in Hong Kong, China. Arthritis Rheum 63:1182–1189

    Article  CAS  PubMed  Google Scholar 

  21. Hao Y, Hudson M, Baron M, Carreira P, Stevens W, Rabusa C et al (2017) Early mortality in a multinational systemic sclerosis inception cohort. Arthritis Rheum 69:1067–1077

    Article  Google Scholar 

  22. Chiang CL (1968) The life table and its construction. In: Introduction to stochastic processes in Bioststatistics. John Wiley & Sons, New York, pp 189–214

    Google Scholar 

  23. Newell C (1994) Methods and Models in Demography. John Wiley & Sons, Chichester(UK), pp 63–81

    Google Scholar 

  24. Kuo CF, See LC, Yu KH, Chou IJ, Chang HC, Chiou MJ, Luo SF (2011) Incidence, cancer risk and mortality of dermatomyositis and polymyositis in Taiwan: a nationwide population study. Br J Dermatol 165:1273–1279

    Article  PubMed  Google Scholar 

  25. Chen IJ, JanWu YJ, Lin CW, Fan KW, Luo SF, Ho HH et al (2009) Interstitial lung disease in polymyositis and dermatomyositis. Clin Rheumatol 28:639–646

    Article  PubMed  Google Scholar 

  26. Obert J, Freynet O, Nunes H, Brillet PY, Miyara M, Dhote R, Valeyre D, Naccache JM (2016) Outcome and prognostic factors in a French cohort of patients with myositis-associated interstitial lung disease. Rheumatol Int 36(12):1727–1735

    Article  PubMed  Google Scholar 

  27. Chen W, Zheng R, Baade PD, Zhang S, Zeng H, Bray F, Jemal A, Yu XQ, He J (2016) Cancer statistics in China, 2015. CA Cancer J Clin 66:115–132

    Article  PubMed  Google Scholar 

  28. Wu C, Wang Q, He L, Yang E, Zeng X (2018) Hospitalization mortality and associated risk factors in patients with polymyositis and dermatomyositis: a retrospective case-control study. PLoS One 13(2):e0192491

    Article  PubMed  PubMed Central  Google Scholar 

  29. Marie I, Menard JF, Hachulla E, Cherin P, Benveniste O, Tiev K et al (2011) Infectious complications in polymyositis and dermatomyositis: a series of 279 patients. Semin Arthritis Rheum 41:48–60

    Article  PubMed  Google Scholar 

  30. Chen IJ, Tsai WP, Wu YJ, Luo SF, Ho HH, Liou LB et al (2010) Infections in polymyositis and dermatomyositis: analysis of 192 cases. Rheumatology 49:2429–2437

    Article  PubMed  Google Scholar 

  31. Schiopu E, Phillips K, MacDonald PM, Crofford LJ, Somers EC (2012) Predictors of survival in a cohort ofpatients with polymyositis and dermatomyositis: effect of corticosteroids, methotrexate and azathioprine. Arthritis Res Ther 14:R22

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  32. Marie I, Hachulla E, Chérin P, Hellot MF, Herson S, Levesque H et al (2005) Opportunistic infectionsin polymyositis and dermatomyositis. Arthritis Rheum 53:155–165

    Article  PubMed  Google Scholar 

  33. Gordon PA, Winer JB, Hoogendijk JE et al (2012) Immunosuppressant andimmunomodulatory treatment for dermatomyositis and polymyositis. Cochrane Database Syst Rev 8:CD003643

    Google Scholar 

  34. Vermaak E, Tansley SL, McHugh NJ (2015) The evidence for immunotherapy indermatomyositis and polymyositis: a systematic review. Clin Rheumatol 34:2089–2095

    Article  PubMed  Google Scholar 

  35. Redondo-Benito C, Villar-Gomez, Trallero-Araguas, Fernández-Codina, Pinal-Fernandez, Rodrigo-Pendás J, Selva-O'Callaghan (2018) Opportunistic infections in patients with idiopathic inflammatory myopathies. Int J Rheum Dis 21(2):487–496

    Article  CAS  PubMed  Google Scholar 

  36. Brandt D, Gershwin ME (2006) Common variable immunedeficiency and autoimmunity. Autoimmun Rev 5:465–470

    Article  CAS  PubMed  Google Scholar 

  37. Tha-In T, Bayry J, Metselaar HJ et al (2008) Modulation of thecellular immune system by intravenousimmunoglobulin. Trends Immunol 29:608–615

    Article  CAS  PubMed  Google Scholar 

  38. Kaveri SV, Lacroix-Desmazes S, Bayry J (2008) The antiinflammatory IgG. N Engl J Med 359:307–309

    Article  CAS  PubMed  Google Scholar 

  39. Jordan SC, Toyoda M, Vo AA (2009) Intravenous immunoglobulin a natural regulator of immunity and inflammation. Transplantation 88:1–6

    Article  CAS  PubMed  Google Scholar 

  40. Lundberg IE, Tjarnlund A, Bottai M, Werth VP, Pilkington C, de Visser M et al (2017) 2017 European league against rheumatism/American College of Rheumatology Classification Criteria for adult and juvenile idiopathic inflammatory myopathies and their major subgroups. Arthritis Rheum 69(12):2271–2282

    Article  Google Scholar 

Download references

Acknowledgments

We thank our patients with PM/DM participating in this study.

Author information

Author notes

  1. Xinlei Yang and Yanjie Hao contributed equally to this work.

Authors and Affiliations

  1. Department of Rheumatology and Clinical Immunology, Peking University First Hospital, 8 Xishiku St, Beijing, 100034, People’s Republic of China

    Xinlei Yang, Yanjie Hao, Xiaohui Zhang, Yan Geng, Lanlan Ji, Guangtao Li & Zhuoli Zhang

Authors
  1. Xinlei Yang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yanjie Hao
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Xiaohui Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yan Geng
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Lanlan Ji
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Guangtao Li
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Zhuoli Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

ZLZ:study conception and design, analysis and interpretation of data, article revision and approval of the final version. YJH: study conception and design, analysis and interpretation of data, drafting of the article and approval of the final version. XLY: acquisition of data, analysis and interpretation of data, drafting of the article, article revision and approval of the final version. Others: acquisition of data, article revision and approval of the final version.

Corresponding author

Correspondence to Zhuoli Zhang.

Ethics declarations

Ethics approval and consent to participate

The ethics approval was obtained from the human research ethics committees of Peking University First Hospital.

Disclosures

None.

Additional information

Publisher’s note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Electronic supplementary material

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Yang, X., Hao, Y., Zhang, X. et al. Mortality of Chinese patients with polymyositis and dermatomyositis. Clin Rheumatol 39, 1569–1579 (2020). https://doi.org/10.1007/s10067-019-04910-w

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-019-04910-w

Keywords

Search

Navigation